Literature DB >> 10807455

Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction.

J K French1, T A Hyde, I T Straznicky, J Andrews, M Lund, D J Amos, A Zambanini, C J Ellis, B J Webber, S C McLaughlin, R M Whitlock, S O Manda, H Patel, H D White.   

Abstract

OBJECTIVES: To evaluate the corrected Thrombolysis in Myocardial Infarction (TIMI) frame count (CTFC) as a predictor of late survival after myocardial infarction.
BACKGROUND: Thrombolysis in Myocardial Infarction flow grades predict late survival after myocardial infarction. The CTFC provides a more reproducible measurement of infarct-related artery blood flow than the TIMI flow grade, and has been linked to 30-day outcomes, but it has not yet been established how the CTFC correlates with late survival.
METHODS: Of 1,001 patients with acute myocardial infarction presenting within 4 h of symptom onset, 882 underwent angiography at approximately three weeks. Infarct artery flow was assessed, blinded to clinical outcomes, according to the CTFC and TIMI flow grade. Late cardiac mortality and survival were determined in 97.5% of patients.
RESULTS: The mean CTFC was 40 +/- 29 in 644 patent infarct arteries (median, 34 [interquartile range, 24 to 47]). The CTFC, assessed as a continuous univariate variable, was found to be a predictor of five-year survival, as was the TIMI flow grade (both p < 0.001). On multivariate analysis, factors associated with five-year survival included the ejection fraction or end-systolic volume index (both p < 0.001); exercise duration (p = 0.005), age (p = 0.008), diabetes (p = 0.02) and CTFC (p = 0.02) or TIMI flow (p = 0.02). The same factors, except for the CTFC and TIMI flow grade, were predictors of 10-year survival.
CONCLUSIONS: The CTFC three weeks after myocardial infarction was an independent predictor of five-year survival, but not 10-year survival. Although the CTFC provided additional prognostic information within TIMI flow grades, its superiority was not demonstrated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807455     DOI: 10.1016/s0735-1097(00)00577-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

1.  Contrast echocardiography accurately predicts myocardial perfusion before angiography during acute myocardial infarction.

Authors:  Gregory B Schnell; Albert J Kryski; Luana Mann; Todd J Anderson; Israel Belenkie
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

2.  Sex and Gender Differences in Ischemic Heart Disease: Endocrine Vascular Disease Approach (EVA) Study Design.

Authors:  Valeria Raparelli; Marco Proietti; Andrea Lenzi; Stefania Basili
Journal:  J Cardiovasc Transl Res       Date:  2018-12-03       Impact factor: 4.132

3.  The Effects of Percutaneous Coronary Intervention on the Flow in Acute Coronary Syndrome Patients-Geometry in Focus.

Authors:  Agnes Orsolya Racz; Ildiko Racz; Gabor Tamas Szabo; Aron Uveges; Zsolt Koszegi; Bence Penczu; Rudolf Kolozsvari
Journal:  J Pers Med       Date:  2022-07-31

4.  Corrected thrombolysis in myocardial infarction frame count and ejection fraction in patients undergoing primary percutaneous coronary intervention for myocardial infarction.

Authors:  Hossein Vakili; Roxana Sadeghi; Mahdiyeh Tabkhi; Morteza Safi
Journal:  ARYA Atheroscler       Date:  2013-03

5.  TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  John W Petersen; B Delia Johnson; Kevin E Kip; R David Anderson; Eileen M Handberg; Barry Sharaf; Puja K Mehta; Sheryl F Kelsey; C Noel Bairey Merz; Carl J Pepine
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.